MolNFT v1 · #157675 · protein
Oxa-23 mutant F110A/M221A low pH form meropenem complex
6N6V · Beta-lactamase: “Oxa-23 mutant F110A/M221A low pH form meropenem complex”. X-ray diffraction, 1 ligand (KE1), 2 pockets (best druggability 0.37). MolNFT v1 #157675 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6N6V
- Type
- protein
- Length
- 230 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase
- EC
- 3.5.2.6
- UniProt
- Q9L4P2
- Ligands
- KE1
- Pockets
- 2 · best druggability 0.37
Structure
x-ray diffraction · 1 distinct chain · 38% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase (EC 3.5.2.6) | protein | 230 | 38% helix, 23% strand | Q9L4P2 |
Ligands and binding sites
- KE1 · meropenem, bound form · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 85 | 0.37 | 0.76 | 17 | empty |
| 2 | 74 | 0.28 | 0.72 | 17 | KE1 |
Modifications
Observed in the structure: 1 covalent (covalent ligand).
Compared structures
- 6N6V · OXA-23 mutant F110A/M221A low pH form meropenem complex · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9L4P2
- Elsewhere: RCSB PDB 6N6V · PDBe 6N6V · UniProt Q9L4P2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.